Market›Consumer Discretionary›Diversified Consumer Services›Specialized Consumer Services
ALLURION TECHNOLOGIE

ALUR

$0.75Apr 26, 2021 – Apr 24, 2026
Consumer DiscretionaryDiversified Consumer ServicesSpecialized Consumer Services$12M
MVM
+$0.6M
TD Variance
1.000

Every news event mapped to its market reaction — 82 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-01-23+184.7%newsSeeking AlphaAllurion stock soars 70% on weight-loss therapy update
2025-01-24+86.8%newsSeeking AlphaAllurion extends rally despite $7.4M stock and warrants offering
2025-01-24+86.8%newsInvestopediaAllurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs - Investopedia
2025-03-21+49.8%newsWall Street PitAllurion Stock Soars on Promising GLP-1 Combo Results - Wall Street Pit
2025-03-20+49.7%newsSeeking AlphaAllurion surges on weight loss data from gastric balloon, GLP-1 combo treatment
2026-03-12+44.4%newsBusiness WireAllurion Advances Plan to Regain Listing Compliance
2026-03-12+44.4%newsTradingViewAllurion Technologies Received Notice of Delisting - TradingView
2026-03-12+44.4%newsBusiness WireAllurion Advances Plan to Regain Listing Compliance - Business Wire
2026-02-27-43.5%newsZacksAre Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?
2026-02-27-43.5%newsYahoo FinanceAre Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year? - Yahoo Finance
2024-11-13-43.1%earningsSeeking AlphaAllurion Technologies reports Q3 results
2024-11-13-43.1%earningsSeeking AlphaAllurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript
2026-03-02-40.7%newsBusiness WireAllurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
2026-03-02-40.7%newsTipRanksAllurion Technologies Appeals NYSE Delisting, Plans Compliance Strategy - TipRanks
2026-03-02-40.7%newsTradingViewAllurion Technologies Received Notice of Delisting - TradingView
2025-02-19-35.3%newsSeeking AlphaAllurion to raise $6.1 million in direct offering and private placement
2026-03-18+35.0%earningsIntellectia AIALUR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
2026-03-10-32.2%newsTradingViewALUR Stock Price and Chart — OTC:ALUR - TradingView
2026-02-24-31.3%newsBusiness WireAllurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
2026-02-24-31.3%analystMT NewswiresChardan Upgrades Allurion Technologies to Buy From Neutral, $3 Price Target
2026-02-24-31.3%newsSeeking AlphaAllurion announces exercise of warrants for $3M in gross proceeds
2026-02-24-31.3%newsBusiness WireAllurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Business Wire
2026-02-24-31.3%analystInvesting.comAllurion Technologies stock rating upgraded on FDA approval - Investing.com
2026-02-24-31.3%M&AStocksToTradeStrategic Acquisition Amplifies Allurion’s Market Presence - StocksToTrade
2026-02-24-31.3%newstimothysykes.comALUR Sees Market Volatility Amidst Strategic Moves and Market Challenges - timothysykes.com
2023-08-10-26.5%newsQuiver QuantitativeALUR | ALLURION TECHNOLOGIES INC Stock Data, Price & News - Quiver Quantitative
2026-02-23+25.1%legalMT NewswiresAllurion Technologies Says Gastric Balloon System to Treat Obesity Premarket Approval Application Approved by FDA
2026-02-23+25.1%legalBusiness WireAllurion Receives U.S. FDA Approval
2026-02-23+25.1%legalInvesting.comAllurion stock surges 40% on U.S. FDA approval - Investing.com
2026-02-23+25.1%newsStocktwitsWhy Did Allurion Stock Surge Over 50% Today? - Stocktwits
2026-02-23+25.1%expansionStocksToTradeAllurion’s Strategic Partnership to Boost Weight Loss Solutions - StocksToTrade
2026-02-23+25.1%legalBusiness WireAllurion Receives U.S. FDA Approval - Business Wire
2026-02-23+25.1%legalStock TitanAllurion (NYSE: ALUR) secures FDA PMA for Smart Capsule obesity device - Stock Titan
2024-12-24+23.7%newsSeeking AlphaAllurion Technologies to implement reverse stock split
2025-05-13+22.9%earningsYahoo FinanceWhat To Expect From Allurion Technologies Inc (ALUR) Q1 2025 Earnings - Yahoo Finance
2026-03-11+21.6%newsBusiness WireAllurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy
2025-05-14+21.0%earningsSeeking AlphaAllurion outlines path to FDA submission and expects revenue ramp as B2B2C strategy expands in 2025
2025-05-14+21.0%earningsSeeking AlphaAllurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript
2025-05-14+21.0%earningsSeeking AlphaAllurion Technologies GAAP EPS of $0.20 beats by $1.61, revenue of $5.6M beats by $0.1M
2024-10-02+18.6%newsSeeking AlphaAllurion started at buy by Jefferies ahead of data for obesity therapy
2024-06-24-18.0%legalSeeking AlphaAllurion Technologies: Study Results Cause Rally, But I'm Awaiting 2024 FDA Catalyst - Seeking Alpha
2024-06-11+15.7%newsYahoo FinanceAllurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
2025-11-11-14.1%earningsYahoo FinanceAllurion Technologies Inc (ALUR) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
2025-11-11-14.1%legalInvesting.comAllurion stock soars after FDA milestones and debt exchange announcement - Investing.com
2025-11-11-14.1%legalBioSpaceAllurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing - BioSpace
2024-11-16+11.0%earningsYahoo FinanceEarnings Release: Here's Why Analysts Cut Their Allurion Technologies Inc. (NYSE:ALUR) Price Target To US$1.83 - Yahoo Finance
2023-08-04+10.5%newsZacks Investment ResearchAllurion Technologies, Inc. (ALUR) - Zacks Investment Research
2023-08-04+10.5%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Allurion Technologies, Inc. (ALUR) - Zacks Investment Research
2023-08-04+10.5%earningsZacks Investment ResearchWhat date does Allurion Technologies, Inc.'s (ALUR) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research
2025-11-12-9.1%earningsSeeking AlphaAllurion signals sequential revenue growth into 2026 as FDA review nears completion
2025-11-12-9.1%earningsSeeking AlphaAllurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript
2025-11-12-9.1%earningsSeeking AlphaAllurion Technologies GAAP EPS of -$1.53, revenue of $2.65M
2026-02-25-8.4%newsBenzingaWhat's Going On With Allurion Stock On Wednesday? - Allurion Technologies (OTC:ALUR) - Benzinga
2026-02-25-8.4%newsInvesting.comAllurion Technologies amends warrant terms and raises $3 million through inducement offer - Investing.com
2024-09-06+8.4%newsSeeking AlphaAllurion started at buy by Roth MKM over weight-loss device potential
2025-03-08-7.6%newsSeeking AlphaWeight-loss drug battle: Who are the latest players involved
2024-08-15-6.8%newsSeeking AlphaAllurion receives continued listing standards notice from NYSE
2023-08-05+6.6%newsYahoo FinanceAllurion Technologies Inc. WT (ALUR-WT) Stock Price, News, Quote & History - Yahoo Finance
2024-12-10-6.6%legalSeeking AlphaAllurion Technologies files for $100M mixed securities shelf
2024-12-10-6.6%newsSeeking AlphaAllurion Technologies files to sell common stock, warrants
2024-10-24+6.3%newsYahoo FinanceALUR Stock Declines Despite Submitting PMA for Allurion Balloon - Yahoo Finance
2024-04-08-5.5%newsChartMillALUR Stock Price, Quote & Chart | ALLURION TECHNOLOGIES INC (NYSE:ALUR) - ChartMill
2025-12-20-5.4%newsThe Globe and MailAllurion Shareholders Approve Governance Changes and Capital Actions - The Globe and Mail
2025-03-26+4.4%earningsSeeking AlphaAllurion Technologies Inc. (ALUR) Q4 2024 Earnings Call Transcript
2025-03-26+4.4%earningsSeeking AlphaAllurion Technologies Inc. 2024 Q4 - Results - Earnings Call Presentation
2025-03-26+4.4%earningsSeeking AlphaAllurion Technologies misses Q4 top-line and bottom-line estimates; initiates FY25 outlook
2026-02-26-3.8%newsThe Globe and MailAllurion Technologies Amends Warrants to Bolster Liquidity - The Globe and Mail
2025-08-13-3.8%expansionSeeking AlphaAllurion pivots to combination therapy strategy while pursuing U.S. market launch
2025-08-13-3.8%earningsSeeking AlphaAllurion Technologies Inc. (ALUR) Q2 2025 Earnings Call Transcript
2025-08-13-3.8%earningsSeeking AlphaAllurion Technologies reports Q2 results
2026-02-03-3.5%expansionBusiness WireAllurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices
2026-02-03-3.5%newsSeeking AlphaPricey consumer discretionary stocks with halting momentum - low momentum and high valuation
2024-09-05-2.6%newsSeeking AlphaAllurion receives non-compliance notice from NYSE
2026-01-12+2.4%newsSeeking AlphaAllurion expects FY25 net sales of 15M
2023-11-21-2.3%newsCoinCodexAllurion Technologies Inc. (ALUR) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2025-01-15-2.3%earningsSeeking AlphaAllurion announces $2.5 million private placement; expects Q4 revenue of $5.6 million
2026-04-20+2.1%newsBusiness WireAllurion Treats First Commercial Patients in the United States, Marking Major Milestone
2026-04-20+2.1%newsStock TitanAs some quit GLP-1 drugs, Allurion starts treating U.S. patients - Stock Titan
2026-02-13+1.7%newsStock TitanALUR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
2026-04-16-1.5%newsMinichartAllurion Technologies Inc. WT (ALUR-WT) - Minichart
2023-02-09+0.6%M&ABusiness WireAllurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp. - Business Wire
2025-04-25+0.5%newsStock TitanALUR Stock Price, News & Analysis - Stock Titan
tickerdossier.comtickerdossier.substack.com